Purpose
to develop a vaccine vector based on a prototype vaccine for herpes simplex virus 2 (HSV-2) that encodes multiple CD8 T cell epitopes from HIV proteins, and test its ability to stimulate a robust CD8 T cell response against HIV
Grantee
Division
Global Health
Date
MAY 2009
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
12
Grantee location
St. Louis, Missouri, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.